Get started
Author

Andrzej Antczak

Observed names: A Antczak, A. ANTCZAK, A. Antczak, Andrzej ANTCZAK, Antczak, Andrzej
Observed institutions: Poznan University of Medical Sciences, Medical University of Warsaw, Nicolaus Copernicus University, International Institute for Molecular Oncology, Greater Poland Cancer Center, Medical University of Lodz, International Hereditary Cancer Center, Pomeranian Medical University
ORCID: 0000-0002-2904-5275
Observed ORCID: 0000-0002-2904-5275
OpenAlex ID: A5049534942
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
2019 · David J. Clark, Saravana M. Dhanasekaran, et al. · Cell · 754
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
2022 · Yize Li, Tung-Shing M. Lih, et al. · Cancer Cell · 252
PDF
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer
2006 · C Cybulski, D Wokołorczyk, et al. · Journal of Medical Genetics · 115
An inherited NBN mutation is associated with poor prognosis prostate cancer
2012 · C Cybulski, D Wokołorczyk, et al. · British Journal of Cancer · 105
PDF
Molecular insights into genome-wide association studies of chronic kidney disease-defining traits
2018 · Xiaoguang Xu, James M. Eales, et al. · Nature Communications · 74
PDF
Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney
2021 · James M. Eales, Xiao Jiang, et al. · Nature Genetics · 73
PDF
Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics
2019 · Joshua Rowland, Artur Akbarov, et al. · Kidney International · 57
PDF
Comprehensive proteogenomic characterization of rare kidney tumors
2024 · Ginny Xiaohe Li, Lijun Chen, et al. · Cell Reports Medicine · 56
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
2021 · Wojciech A. Cieślikowski, Andrzej Antczak, et al. · Biomedicines · 55
PDF
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
2020 · Xiao Jiang, James M Eales, et al. · European Heart Journal · 53
PDF
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
2020 · Wojciech A. Cieślikowski, Joanna Budna-Tukan, et al. · Cancers · 44
PDF
PALB2 mutations and prostate cancer risk and survival
2021 · Dominika Wokołorczyk, Wojciech Kluźniak, et al. · British Journal of Cancer · 43
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland
2013 · Wojciech Kluźniak, Dominika Wokołorczyk, et al. · The Prostate · 36
BRCA1 mutations and prostate cancer in Poland
2008 · Cezary Cybulski, Bohdan Górski, et al. · European Journal of Cancer Prevention · 33
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
2019 · Joanna Budna-Tukan, Monika Świerczewska, et al. · Cancers · 32
PDF
A prospective randomized trial: A comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic Castrate Resistance prostate cancer (m
2013 · M. BACZYK, P. MILECKI, et al. · Neoplasma · 32
Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets
2024 · Xiaoguang Xu, Chachrit Khunsriraksakul, et al. · Nature Communications · 30
PDF
A common nonsense mutation of the BLM gene and prostate cancer risk and survival
2013 · Andrzej Antczak, Wojciech Kluźniak, et al. · Gene · 26
Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High‐Risk Prostate Cancer
2009 · Piotr Milecki, Maciej Baczyk, et al. · BioMed Research International · 24
PDF
Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC)
2013 · Michał Hrab, Karolina Olek-Hrab, et al. · Reports of Practical Oncology & Radiotherapy · 22
PDF
A personalised approach to prostate cancer screening based on genotyping of risk founder alleles
2013 · C Cybulski, D Wokołorczyk, et al. · British Journal of Cancer · 18
PDF
Comparison of dose volume histograms for supine and prone position in patients irradiated for prostate cancer—A preliminary study
2011 · Tomasz Bajon, Tomasz Piotrowski, et al. · Reports of Practical Oncology & Radiotherapy · 18
Reasons behind the Delayed Diagnosis of Testicular Cancer: A Retrospective Analysis
2023 · Wojciech A. Cieślikowski, Michał Kasperczak, et al. · International Journal of Environmental Research and Public Health · 15
PDF
Attitudes about Testicular Self-Examination among Polish Males
2021 · Tomasz Milecki, Natalia Majchrzak, et al. · Biology · 15
PDF
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
2023 · Wojciech A. Cieślikowski, Piotr Milecki, et al. · Journal of Personalized Medicine · 14
PDF
Works count: 69
Citation count: 2,113
H-index: 20
I10-index: 27
Year
Topic
Type